Fresenius SE / Half Year Results/Preliminary Results 27.07.2010 19:10 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- First half of 2010: Preliminary Group net income substantially better than expected â Earnings outlook raised Based on preliminary results, Fresenius Group earnings for the first half of 2010 were substantially ahead of expectations. Group net income* increased by 23% in constant currency to EUR302 million (H1 2009: EUR240 million). The earnings development was mainly driven by Fresenius Kabi, especially in North America, where new product launches and strong demand due to drug shortages contributed to growth. Fresenius Kabi also expects to achieve attractive growth in the second half of 2010, albeit more in line with the initial 2010 guidance. In addition, Fresenius Kabi plans to invest in further efficiency improvements in Europe, resulting in expected one-time expenses of approximately EUR10 million to EUR20 million pre-tax in the second half of 2010. Based on the Group's financial results in the first half and including the planned one-time expenses, Fresenius now expects net income* to increase by 10% to 15% in constant currency in 2010. Previously, the Company expected net income to increase by 8% to 10% in constant currency. The detailed financial results for the first half of 2010 will be announced on August 3, 2010, as originally scheduled. *Net income attributable to Fresenius SE; adjusted for the effects of mark-to-market accounting of the Mandatory Exchangeable Bonds (MEB) and the Contingent Value Rights (CVR) related to the acquisition of APP Pharmaceuticals. Both are non-cash items. The Management Board Bad Homburg v.d.H., July 27, 2010 End of note 27.07.2010 19:10 Ad hoc announcement, Financial News and Press Release distributed by DGAP. Medienarchiv at |[![CDATA[|[a href="http://www.dgap-medientreff.de"|]www.dgap-medientreff.de|[/a|]]]|] and |[![CDATA[|[a href="http://www.dgap.de"|]www.dgap.de|[/a|]]]|] --------------------------------------------------------------------------- Language: English Company: Fresenius SE Else-Kröner-StraÃe 1 61352 Bad Homburg v.d.H. Deutschland Phone: +49 (0)6172 608-2485 Fax: +49 (0)6172 608-2488 E-mail: ir-fre@fresenius.com Internet: www.fresenius.com ISIN: DE0005785638, DE0005785604 WKN: 578563, 578560 Indices: DAX Listed: Regulierter Markt in Frankfurt (Prime Standard), Düsseldorf, München; Freiverkehr in Berlin, Hannover, Stuttgart, Hamburg; Terminbörse EUREX End of News DGAP News-Service ---------------------------------------------------------------------------
DGAP-Adhoc: Fresenius SE: First half of 2010: Preliminary Group net income substantially better than expected â Earnings outlook raised
| Source: EQS Group AG